By KIM BELLARD A New York Times interview with Rep. Jake Auchincloss (D – Mass) by Bret Stephens caught my attention. I am somewhat familiar with Mr. Stephens from his various pieces in NYT; he is definitely a conservative, but in the old, pre-MAGA sense where it meant you worried about spending but you didn’t…
This year, the Nobel Prize in medicine went to Victor Ambros, currently a Professor of Natural Science at the University of Massachusetts Medical School, and Gary Ruvkun, a Professor of Genetics at Harvard Medical School. The two men won the award for their discovery of microRNA. One of the key questions of science is figuring…
Drug makers sometimes offer copay coupons to lower consumers’ out-of-pocket costs for their brand-name prescriptions, though how private health plans treat those coupons can substantially limit their value to consumers. This issue brief provides an overview of such copay adjustment programs, stakeholder arguments for and against their use, their prevalence, and federal and state efforts…
Several states have joined President Donald Trump’s deportation efforts and are taking federal reporting requirements to immigration authorities a step further — by using their public health agencies as arms of enforcement. North Carolina, in late April, became the latest member of a growing group of Republican-led states to require their public health agencies to…
Pear Suite recently won the payer/provider technology track of MedCity News’ INVEST Pitch Perfect contest. The startup provides a software platform for community health workers that helps them share data, submit claims and maintain compliance. The post INVEST Pitch Perfect Spotlight: How Pear Suite Makes Sure Community Health Workers Get Paid appeared first on MedCity…
BridgeBio Pharma claims its drug, Attruby, has an edge over a Pfizer drug as a treatment for cardiomyopathy caused by transthyretin-mediated amyloidosis. But new competition to both products could come soon from Alnylam Pharmaceuticals, now set to receive an FDA decision in this indication by late March. The post FDA Nod for BridgeBio Brings New…
María Sánchez emigró al área de Chicago desde México hace unos 30 años. Ahora, a sus 87, sigue viviendo en Estados Unidos sin papeles. Como muchos inmigrantes de larga data, ha trabajado —y pagado impuestos, incluyendo para Medicare— durante todo ese tiempo. Pero Sánchez nunca tuvo seguro médico, y cuando cumplió 65, no pudo inscribirse…
By MATTHEW HOLT This is the week where the digital health landscape debunks to the HLTH Conference in Vegas to meet, do deals, listen to superannuated rappers and generally have a great time. Speaking as the guy who ran the digital health conference before HLTH emerged, I remain extremely jealous of how Jonathan Weiner, Rich…
To provide context for emerging debates about federal actions to address prescription drug costs, this issue brief highlights five key facts about Medicaid prescription drug coverage, payment, and administration.
This brief explores the magnitude of federal funding cuts under the House budget resolution and puts the $880 billion in context by comparing the size of the cuts to states’ tax revenues, spending on education, and the number of Medicaid enrollees covered for that cost.